35 related articles for article (PubMed ID: 7365696)
1. Synthesis and biological evaluation of indolyl-pyridinyl-propenones having either methuosis or microtubule disruption activity.
Trabbic CJ; Overmeyer JH; Alexander EM; Crissman EJ; Kvale HM; Smith MA; Erhardt PW; Maltese WA
J Med Chem; 2015 Mar; 58(5):2489-512. PubMed ID: 25654321
[TBL] [Abstract][Full Text] [Related]
2. Involvement of central dopamine receptors in the hypotensive action of pergolide.
Jadhav AL; Willett RN; Sapru HN; Lokhandwala MF
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):281-6. PubMed ID: 6664381
[TBL] [Abstract][Full Text] [Related]
3. Vasodilator response to dopamine in the ferret pulmonary circulation.
Gorman P
Br J Pharmacol; 1988 May; 94(1):212-8. PubMed ID: 2900036
[TBL] [Abstract][Full Text] [Related]
4. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
[TBL] [Abstract][Full Text] [Related]
5. New dopamine receptor agonists in heart failure and hypertension. Implications for future therapy.
Horn PT; Murphy MB
Drugs; 1990 Oct; 40(4):487-92. PubMed ID: 1982088
[No Abstract] [Full Text] [Related]
6. Vascular dopamine receptor as a model for other dopamine receptors.
Goldberg LI
Adv Biochem Psychopharmacol; 1978; 19():119-29. PubMed ID: 358776
[No Abstract] [Full Text] [Related]
7. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
Kohli JD; Goldberg LI; Volkman PH; Cannon JG
J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
[TBL] [Abstract][Full Text] [Related]
8. Similarities and differences of dopamine receptors in the renal vascular bed and elsewhere.
Goldberg LI; Volkman PH; Kohli JD; Kotake AN
Adv Biochem Psychopharmacol; 1977; 16():251-6. PubMed ID: 196488
[No Abstract] [Full Text] [Related]
9. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
Goldberg LI; Kohli JD; Cantacuzene D; Kirk KL; Creveling CR
J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
[TBL] [Abstract][Full Text] [Related]
10. Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.
Listinsky JJ; Kohli JD; Goldberg LI
J Pharmacol Exp Ther; 1980 Dec; 215(3):662-7. PubMed ID: 6108364
[TBL] [Abstract][Full Text] [Related]
11. Continuing studies of the peripheral vascular actions of dopamine.
Goldberg LI; Tjandramaga TB; Anton AH; Toda N
Adv Neurol; 1974; 5():165-73. PubMed ID: 4440569
[No Abstract] [Full Text] [Related]
12. Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors.
Kohli JD; Weder AB; Goldberg LI; Ginos JZ
J Pharmacol Exp Ther; 1980 May; 213(2):370-4. PubMed ID: 7365696
[No Abstract] [Full Text] [Related]
13. [New inotropic agents in the treatment of congestive heart failure].
Freitas M
Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
